Literature DB >> 15019029

Concerning the stability of benzyl alcohol: formation of benzaldehyde dibenzyl acetal under aerobic conditions.

Andreas M Abend1, Le Chung, Richard Todd Bibart, Marvin Brooks, David G McCollum.   

Abstract

An impurity in benzyl alcohol was identified as benzaldehyde dibenzyl acetal (BDBA). The component BDBA is reversibly formed by the reaction of benzyl alcohol with benzaldehyde, an oxidative degradation product of benzyl alcohol. Whereas, BDBA is a known chemical entity, it is not typically controlled in commercial benzyl alcohol since it cannot be formed in the absence of benzaldehyde, which is itself generally controlled. However, once commercial benzyl alcohol is exposed to the atmosphere, formation of BDBA is possible. The synthesis and characterization of BDBA is reported. The ability of BDBA to react with alcohols to form other types of acetals, and the impact of low levels of BDBA on the quantitative analysis of pharmaceutical products, are considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019029     DOI: 10.1016/j.jpba.2003.11.007

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Photoredox Cross-Coupling: Ir/Ni Dual Catalysis for the Synthesis of Benzylic Ethers.

Authors:  Idris Karakaya; David N Primer; Gary A Molander
Journal:  Org Lett       Date:  2015-06-16       Impact factor: 6.005

2.  Risk evaluation of impurities in topical excipients: The acetol case.

Authors:  Jente Boonen; Lieselotte Veryser; Lien Taevernier; Nathalie Roche; Kathelijne Peremans; Christian Burvenich; Bart De Spiegeleer
Journal:  J Pharm Anal       Date:  2014-01-08

3.  Characterization of pore structure in biologically functional poly(2-hydroxyethyl methacrylate)-poly(ethylene glycol) diacrylate (PHEMA-PEGDA).

Authors:  Amelia Zellander; Chenlin Zhao; Mrignayani Kotecha; Richard Gemeinhart; Melissa Wardlow; Jeremiah Abiade; Michael Cho
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.